2022 Pharma Marketer’s Guide to SEM FDA Compliance

The 2022 report on the State of SEM FDA Non-Compliance is for Pharma marketers to help prevent FDA Warning Letters from shutting down their brand campaigns. 

Highlights from the report include the following: 

• Recap of Recent SEM Warning Letters and FDA Corrective Actions 

• Total SEM Non-Compliant Brands Detected in 2021

• Avg. Duration of SEM Non-Compliance in 2021 vs 2020

• Example 2021 Non-Compliant SEM Ads 

• How to Prevent SEM Non-Compliance in 2022

  Early Access Is Free For All PranifyRx Insights Paid Subscribers

Non-PranifyRx Members: $1,499 (Purchase Report Below).